Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Biochemical and aerosol characterization of ricin for use in non-clinical efficacy studies.

Barnewall RE, Riffle CG, Jones RL, Guistino DJ, Chou RM, Anderson MS, Vassar ML, Howland CA.

J Biochem Mol Toxicol. 2017 Dec;31(12). doi: 10.1002/jbt.21980. Epub 2017 Sep 7.

PMID:
28881502
2.

Chikungunya virus infection in Cynomolgus macaques following Intradermal and aerosol exposure.

Cirimotich CM, Vela EM, Garver J, Barnewall RE, Miller BD, Meister GT, Rogers JV.

Virol J. 2017 Jul 20;14(1):135. doi: 10.1186/s12985-017-0804-7.

3.

Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Savransky V, Sanford DC, Syar E, Austin JL, Tordoff KP, Anderson MS, Stark GV, Barnewall RE, Briscoe CM, Lemiale-Biérinx L, Park S, Ionin B, Skiadopoulos MH.

Infect Immun. 2013 Apr;81(4):1152-63. doi: 10.1128/IAI.01289-12. Epub 2013 Jan 28.

4.

Inhalational monkeypox virus infection in cynomolgus macaques.

Barnewall RE, Fisher DA, Robertson AB, Vales PA, Knostman KA, Bigger JE.

Front Cell Infect Microbiol. 2012 Sep 17;2:117. doi: 10.3389/fcimb.2012.00117. eCollection 2012.

5.

A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N; AVRP Laboratory Working Group.

Clin Vaccine Immunol. 2012 Nov;19(11):1730-45. doi: 10.1128/CVI.00324-12. Epub 2012 Aug 29.

6.

Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit model.

Barnewall RE, Comer JE, Miller BD, Gutting BW, Wolfe DN, Director-Myska AE, Nichols TL, Taft SC.

Front Cell Infect Microbiol. 2012 Jun 13;2:71. doi: 10.3389/fcimb.2012.00071. eCollection 2012.

7.

Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment.

Comer JE, Ray BD, Henning LN, Stark GV, Barnewall RE, Mott JM, Meister GT.

Clin Vaccine Immunol. 2012 Sep;19(9):1517-25. doi: 10.1128/CVI.00292-12. Epub 2012 Jul 25.

8.

The pathophysiology of inhalational brucellosis in BALB/c mice.

Henning LN, Gillum KT, Fisher DA, Barnewall RE, Krile RT, Anderson MS, Ryan MJ, Warren RL.

Sci Rep. 2012;2:495. doi: 10.1038/srep00495. Epub 2012 Jul 6.

9.

Pathophysiology of the rhesus macaque model for inhalational brucellosis.

Henning LN, Miller SM, Pak DH, Lindsay A, Fisher DA, Barnewall RE, Briscoe CM, Anderson MS, Warren RL.

Infect Immun. 2012 Jan;80(1):298-310. doi: 10.1128/IAI.05878-11. Epub 2011 Nov 7.

10.

Inhalational botulism in rhesus macaques exposed to botulinum neurotoxin complex serotypes A1 and B1.

Sanford DC, Barnewall RE, Vassar ML, Niemuth N, Metcalfe K, House RV, Henderson I, Shearer JD.

Clin Vaccine Immunol. 2010 Sep;17(9):1293-304. doi: 10.1128/CVI.00080-10. Epub 2010 Jul 21.

11.

Antigen-specific Vgamma2Vdelta2 T effector cells confer homeostatic protection against pneumonic plaque lesions.

Huang D, Chen CY, Ali Z, Shao L, Shen L, Lockman HA, Barnewall RE, Sabourin C, Eestep J, Reichenberg A, Hintz M, Jomaa H, Wang R, Chen ZW.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7553-8. doi: 10.1073/pnas.0811250106. Epub 2009 Apr 21.

12.

Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.

Phipps AJ, Premanandan C, Barnewall RE, Lairmore MD.

Microbiol Mol Biol Rev. 2004 Dec;68(4):617-29. Review.

14.
15.

Supplemental Content

Loading ...
Support Center